pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,256 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT05780710: OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake

Sponsor: Aktiia SA. Phase: NA. Conditions: Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT07412613: Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Sponsor: Akeso. Phase: PHASE3. Conditions: Resectable Colon Cancer, MSI-H/dMMR Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05937620: Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

Sponsor: Fundacion Clinic per a la Recerca Biomédica. Phase: NA. Conditions: Ovarian Epithelial Cancer

full page →ctgov ↗
›TERMINATEDphase readoutNCT04717024: The Nanowear Wearable Covid-19 Observational and Analysis Trend

Sponsor: Nanowear Inc.. Phase: . Conditions: Covid19

full page →ctgov ↗
›COMPLETEDphase readoutNCT06381024: A Study of Telemonitoring in Cancer Patients

Sponsor: Centre Hospitalier de Bligny. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06469970: Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults

Sponsor: Centre Hospitalier Régional Metz-Thionville. Phase: PHASE2. Conditions: Burns, Intensive Care, Emergencies

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06963970: Using Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Dementia, Cancer, Renal Disease, Obstructive Pulmonary Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07432373: Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection

Sponsor: National University of Malaysia. Phase: . Conditions: Pleural Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT07612969: Comparing The Effect of Proprioceptive Neuromuscular Facilitation (PNF) When Coupled With Dry Needling (DN), Acupuncture (AN) or Sham Needling (SN) on Knee Range of Motion (ROM), Jump Height and Unipedal Balance

Sponsor: Mohamad Karam. Phase: NA. Conditions: Healthy Adult Males, Healthy Subjects

full page →ctgov ↗
›RECRUITINGphase readoutNCT07572669: Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: PHASE2. Conditions: Steroid-Refractory Acute Graft-Versus-Host Disease, Acute Graft-Versus-Host Disease, Graft-Versus-Host Disease, Allogeneic Hematopoietic Stem Cell Transplantation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07593183: Comparing the Effects of Lumbar Stability Exercises and Telerehabilitation on Reducing Lumbar Lordotic Angle, Pain, and Disability in Postpartum Women

Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Lumbar Lordotic Angle, Lumbar Pain, Disability

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07406841: Spinal Versus General Anesthesia in Pregnancies With Placenta Accreta Spectrum: A Retrospective Comparative Study

Sponsor: Gaziantep City Hospital. Phase: . Conditions: Placenta Accreta Spectrum

full page →ctgov ↗
›RECRUITINGphase readoutNCT07504341: Physiological Finding in Management of COVID 19 Patients

Sponsor: St. Martin De Porress Hospital. Phase: . Conditions: COVID-19 (Coronavirus Disease 2019)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07306754: A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

Sponsor: AbbVie. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05396105: Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Sponsor: Pharvaris Netherlands B.V.. Phase: PHASE2. Conditions: Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II, Hereditary Angioedema Attack, Hereditary Angioedema With C1 Esterase Inhibitor Deficiency, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, Hereditary Angioedema - Type 3, C1 Esterase Inhibitor [C1-INH] Deficiency, C1 Esterase Inhibitor Deficiency, C1 Esterase Inhibitor, Deficiency of, C1 Inhibitor Deficiency, Hereditary Angioedema Type III, Hereditary Angioedema (HAE), Hereditary Angioedema Type I and II

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07541105: Cancer Awareness Among Syrian Migrants

Sponsor: Toros University. Phase: NA. Conditions: Breast Cancer Screening, Cervical Cancer Screening, Colorectal Cancer Screening, Cancer Prevention Behavior

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07531394: Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke

Sponsor: Capital Medical University. Phase: PHASE3. Conditions: Ischemic Stroke, Acute, Myocardial Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT05535166: Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Medulloblastoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07461766: Food and Nutrition Education for Adolescent Soccer Players

Sponsor: Federal University of São Paulo. Phase: NA. Conditions: Nutritional Assessments, Adolescent Athletic Performance, Premenstrual Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT03524222: Home Hospital for Suddenly Ill Adults

Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Infection, Heart Failure, COPD, Asthma, Gout Flare, Chronic Kidney Diseases, Hypertensive Urgency, Atrial Fibrillation Rapid, Anticoagulants; Increased

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05656651: Acute Immunological Effects of Exercise in Cancer Patients

Sponsor: Universität Duisburg-Essen. Phase: PHASE2. Conditions: Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07473531: Chatbot to Support Healthcare Professionals Experiencing Workplace Aggression

Sponsor: Distrito Sanitario Almeria. Phase: . Conditions: Workplace Violence, Health Professionals, Chatbot, Digital Health

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07427472: "Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Heterozygous Familial Hypercholesterolemia (HeFH)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07465939: Dento-skeletal Effects of Quadhelix Versus Mini-hyrax Expanders in Patients With Cleft Lip and Palate at the Mixed Dentition Stage: A Randomized Clinical Trial

Sponsor: Cairo University. Phase: NA. Conditions: Maxillary Expansion in Cleft Lip and Palate Patients, Dentoskeletal Effects After Expansion Using Two Different Expanders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07569575: Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures

Sponsor: HuaMg Perfection Med Tech (Suzhou) Co., Ltd.. Phase: NA. Conditions: Tibial Fracture, Femoral Fracture, Humeral Fracture

full page →ctgov ↗
›RECRUITINGphase readoutNCT07422675: SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

Sponsor: Serina Therapeutics. Phase: PHASE1. Conditions: PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07439575: Wound Closure Materials and Techniques in Hip and Knee Arthroplasty

Sponsor: Bahattin Kemah. Phase: NA. Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip

full page →ctgov ↗
›RECRUITINGphase readoutNCT06851975: Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

Sponsor: Centre Antoine Lacassagne. Phase: . Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06503575: Adolescent Idiopathic Scoliosis and Body Schema

Sponsor: Acibadem University. Phase: . Conditions: Adolescent Idiopathic Scoliosis, Body Schema

full page →ctgov ↗
›RECRUITINGphase readoutNCT06783595: Peri-implant Mucosal Changes Over Time Following Implant Provisional Removal in the Esthetic Zone

Sponsor: Loma Linda University. Phase: . Conditions: Tooth Loss, Implant Site Reaction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07477067: Exercise and Protein Efficiency in T2D

Sponsor: University of Illinois at Urbana-Champaign. Phase: NA. Conditions: Type 2 Diabetes, Control Condition

full page →ctgov ↗
›RECRUITINGphase readoutNCT06805630: Urine Methylation Markers in UTUC

Sponsor: Duke University. Phase: NA. Conditions: Upper Tract Urothelial Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05603000: Emotion Focused Family Therapy for Parents of Children With Mental Health Difficulties

Sponsor: University of Guelph. Phase: NA. Conditions: Anxiety, Depression, Behavior Problem

full page →ctgov ↗
›RECRUITINGphase readoutNCT06477900: Impact of SMS Reminder on Weight Loss, as Part of a Health Pathway in Patients With Prediabetes (PREDIABCOACH)

Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: NA. Conditions: PreDiabetes

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06445400: A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: HER2-positive Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07359807: A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.

Sponsor: Concept Medical Inc.. Phase: PHASE2. Conditions: Popliteal Artery Disease, Superficial Femoral Artery Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04928807: Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: PHASE3. Conditions: Rectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07582107: Anatomical Landmark Method for Paediatric Port Catheter Tip Positioning

Sponsor: Ankara City Hospital Bilkent. Phase: . Conditions: Central Venous Catheterization, Vascular Access Devices, Pediatric Patients, Monitoring

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07552792: Impact of Hand Rub Placement on Patient Trust and Disease Stigma

Sponsor: Huashan Hospital. Phase: NA. Conditions: Noncommunicable Disease, Psoriasis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07379034: The Effect of ShotBlocker and Vibration on Pain During Vaccination

Sponsor: Ataturk University. Phase: NA. Conditions: Vaccination, Pain, Infant, Shotblocker, Vibration

full page →ctgov ↗
›COMPLETEDphase readoutNCT02432534: Atorvastatin in Active Vitiligo

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE2. Conditions: Vitiligo

full page →ctgov ↗
›RECRUITINGphase readoutNCT06017934: Promoting Increased Physical Activity in Hospitalised Older Adults

Sponsor: University of Southampton. Phase: NA. Conditions: Hospital-associated Deconditioning

full page →ctgov ↗
›RECRUITINGphase readoutNCT06332209: Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Post-Traumatic Stress Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06632509: BD SiteRite(TM) 9 Ultrasound System - Clinical Study

Sponsor: Becton, Dickinson and Company. Phase: . Conditions: BD SiteRite 9 for VAD Insertion

full page →ctgov ↗
›COMPLETEDphase readoutNCT02007499: Pre-arrival Instructions Effect on Bystander Cardiopulmonary Resuscitation (CPR).

Sponsor: Medical College of Wisconsin. Phase: . Conditions: Heart Arrest, Cardiac Arrest, Cardiopulmonary Arrest, Out of Hospital Cardiac Arrest, Sudden Cardiac Death

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01545999: Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Schizophrenia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07105098: NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Sponsor: Neurocrine Biosciences. Phase: PHASE3. Conditions: Schizophrenia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07513363: The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency

Sponsor: Tarik Emre Sener. Phase: NA. Conditions: Overactive Bladder, Vitamin D Deficiency

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05777993: A Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study

Sponsor: Agios Pharmaceuticals, Inc.. Phase: PHASE4. Conditions: Pyruvate Kinase Deficiency, Anemia, Hemolytic

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06832293: My MS and My Menstrual Cycle

Sponsor: University of Alberta. Phase: . Conditions: Multiple Sclerosis, Menstrual Cycle

full page →ctgov ↗
← prev
page 38 of 106
next →